We are live on ! Find out more
R

Rebalance Portfolio holdings

AUM $1.91B Turnover 5.71%
1-Year Est. Return 16.23%
This Fund
S&P 500
This Quarter Est. Return
-2.56%
1 Year Est. Return
+16.23%
3 Year Est. Return
+43.28%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.34B
AUM Growth
-$26.9M
Cap. Flow
+$12.2M
Cap. Flow %
0.91%
Top 10 Hldgs %
81.37%
Holding
102
New
9
Increased
42
Reduced
28
Closed
4
Avg Time Held
1.5 years
Top 10 Avg Time Held
1.9 years
Top 20 Avg Time Held
1.5 years
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
LLY icon
76
Eli Lilly
LLY
$1.12T
$453K 0.03%
587
-8
-1% -$6.62K
2022 Q4
8 quarters
PCG icon
77
PG&E
PCG
$39.2B
$451K 0.03%
22,371
+11
+0% +$224
2023 Q1
7 quarters
MORT icon
78
VanEck Mortgage REIT Income ETF
MORT
$310M
$451K 0.03%
42,432
+2,525
+6% +$28.4K
2022 Q4
8 quarters
TIP icon
79
iShares TIPS Bond ETF
TIP
$14.4B
$428K 0.03%
+4,021
New +$435K
2024 Q4
0 quarters
IBM icon
80
IBM
IBM
$218B
$412K 0.03%
1,875
– –
2023 Q4
4 quarters
WSM icon
81
Williams-Sonoma
WSM
$29.4B
$404K 0.03%
2,180
– –
2023 Q4
4 quarters
DFUS icon
82
Dimensional US Equity ETF
DFUS
$21.1B
$398K 0.03%
6,249
+22
+0.4% +$1.41K
2022 Q4
8 quarters
AMZN icon
83
Amazon
AMZN
$2.68T
$393K 0.03%
1,792
+502
+39% +$103K
2024 Q3
1 quarter
JPM icon
84
JPMorgan Chase
JPM
$898B
$366K 0.03%
1,527
– –
2022 Q4
8 quarters
CAT icon
85
Caterpillar
CAT
$337B
$344K 0.03%
947
+122
+15% +$47.3K
2023 Q4
4 quarters
CRWD icon
86
CrowdStrike
CRWD
$233B
$342K 0.03%
4,000
-700
-15% -$58.2K
2024 Q3
1 quarter
XOM icon
87
ExxonMobil
XOM
$732B
$319K 0.02%
2,967
– –
2022 Q4
8 quarters
XLV icon
88
State Street Health Care Select Sector SPDR ETF
XLV
$45.7B
$311K 0.02%
2,257
+10
+0.4% +$1.46K
2023 Q4
4 quarters
ROK icon
89
Rockwell Automation
ROK
$47.2B
$309K 0.02%
1,083
– –
2022 Q4
8 quarters
VT icon
90
Vanguard Total World Stock ETF
VT
$81.2B
$309K 0.02%
2,632
+105
+4% +$12.6K
2023 Q2
6 quarters
LOW icon
91
Lowe's Companies
LOW
$110B
$309K 0.02%
1,250
– –
2022 Q4
8 quarters
KO icon
92
Coca-Cola
KO
$400B
$253K 0.02%
4,059
– –
2023 Q4
4 quarters
AMP icon
93
Ameriprise Financial
AMP
$44.1B
$251K 0.02%
472
-13
-3% -$6.94K
2023 Q2
6 quarters
RPM icon
94
RPM International
RPM
$12.7B
$246K 0.02%
+2,000
New +$264K
2024 Q4
0 quarters
PEP icon
95
PepsiCo
PEP
$178B
$239K 0.02%
1,575
– –
2023 Q4
4 quarters
VGT icon
96
Vanguard Information Technology ETF
VGT
$146B
$223K 0.02%
2,864
– –
2024 Q3
1 quarter
CVX icon
97
Chevron
CVX
$440B
$217K 0.02%
1,500
– –
2023 Q4
4 quarters
CP icon
98
Canadian Pacific Kansas City
CP
$76.3B
$209K 0.02%
2,884
– –
2023 Q4
4 quarters
BSCT icon
99
Invesco BulletShares 2029 Corporate Bond ETF
BSCT
$2.99B
– –
-37,115
Closed -$698K –
JNJ icon
100
Johnson & Johnson
JNJ
$615B
– –
-1,344
Closed -$218K –

Similar funds

Rebalance's Q4 2024 Portfolio in Review

As of Q4 2024, Rebalance held 102 positions worth $1.34B, down 2% from $1.36B the previous quarter. Its ten largest holdings account for 81% of the portfolio.

Rebalance's Q4 2024 filing shows 9 new, 42 increased, 28 reduced and 4 closed positions. Its largest new stake was iShares iBonds Dec 2027 Term Corporate ETF: 358,509 shares worth $8.59M. The largest sale was Invesco BulletShares 2024 Corporate Bond ETF, an estimated $7.41M.

By sector, the portfolio is most concentrated in Miscellaneous at 98% of assets, down from 99% a quarter earlier, followed by Technology and Financials.

  • Rebalance's largest Q4 2024 buy was iShares iBonds Dec 2027 Term Corporate ETF: 358,509 shares worth $8.59M.
  • Rebalance added most to iShares iBonds Dec 2025 Term Corporate ETF in Q4 2024, an estimated $7.89M increase.
  • Rebalance's biggest Q4 2024 reduction was Invesco BulletShares 2026 Corporate Bond ETF, cutting an estimated $6.93M.
  • Rebalance fully exited Invesco BulletShares 2024 Corporate Bond ETF in Q4 2024, selling an estimated $7.41M.
  • Rebalance's ten largest holdings make up 81% of its $1.34B portfolio in Q4 2024.
  • Rebalance opened 9 new positions and closed 4 in Q4 2024.
  • Rebalance's portfolio value fell 2% quarter-over-quarter to $1.34B.

Based on Rebalance's 13F filing for Q4 2024, filed 7 Feb 2025.